NR584 Quality Improvement Worksheet
Name: Thabiso Sehloho
1. Introduction
The safety of patients is significantly jeopardized by medication mistakes, especially in
situations involving polypharmacy, which are more common among older persons. As advanced
practice nurses (APNs), we must address this issue to maintain the quality and safety standards
that are in place in the healthcare industry. According to other researchers, polypharmacy, which
is defined as the concurrent use of many drugs, is common among older people who have
chronic diseases. This raises the risk of medication mistakes, adverse drug reactions, and
interactions. Polypharmacy, for instance, was shown to be connected with a greater prevalence of
adverse medication responses in older persons, according to studies (Pazan & Wehling, 2021).
2. Quality Measures
Gathering pertinent data is essential to provide direction for quality improvement (QI)
programs aimed at reducing medication mistakes in polypharmacy. APNs are responsible for
monitoring various patient outcomes, including the incidence and kinds of medication mistakes,
adverse drug responses, hospitalizations due to errors, and the outcomes of patients after
treatments (Rodziewicz & Hipskind, 2020). Within the context of older persons, for instance, a
0320 RB/KK
Name: Thabiso Sehloho
1. Introduction
The safety of patients is significantly jeopardized by medication mistakes, especially in
situations involving polypharmacy, which are more common among older persons. As advanced
practice nurses (APNs), we must address this issue to maintain the quality and safety standards
that are in place in the healthcare industry. According to other researchers, polypharmacy, which
is defined as the concurrent use of many drugs, is common among older people who have
chronic diseases. This raises the risk of medication mistakes, adverse drug reactions, and
interactions. Polypharmacy, for instance, was shown to be connected with a greater prevalence of
adverse medication responses in older persons, according to studies (Pazan & Wehling, 2021).
2. Quality Measures
Gathering pertinent data is essential to provide direction for quality improvement (QI)
programs aimed at reducing medication mistakes in polypharmacy. APNs are responsible for
monitoring various patient outcomes, including the incidence and kinds of medication mistakes,
adverse drug responses, hospitalizations due to errors, and the outcomes of patients after
treatments (Rodziewicz & Hipskind, 2020). Within the context of older persons, for instance, a
0320 RB/KK
